Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma

SIMPLE SUMMARY: Darifenacin is a selective muscarinic acetylcholine receptor 3 (M3R) antagonist in clinical use for benign bladder disorders. Here, the effects of M3R blockage by darifenacin on human colon adenocarcinoma cells are analyzed in vitro and in vivo. M3R expression was found in the majori...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancers (Basel)
Main Authors: Hering, Nina A., Liu, Verena, Kim, Rayoung, Weixler, Benjamin, Droeser, Raoul A., Arndt, Marco, Pozios, Ioannis, Beyer, Katharina, Kreis, Martin E., Seeliger, Hendrik
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267754/
https://ncbi.nlm.nih.gov/pubmed/34203220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13133220
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki